HSBC ADR Slides 11% in a Month, Four Days Before the Results Call

HSBC has given back nearly all of the 4.2% gain from its Q3 profit beat, with the ADR closing Thursday at $91.89, down 11% over the past month and now sitting below where it traded before the earnings pop earlier in October.

The reversal has not triggered a fresh wave of short selling. Short interest has actually fallen about 8% over the past month to roughly 4.66 million shares, and the borrow market remains exceptionally loose: availability is running at nearly 5,000% of existing short interest, meaning there are close to 26 million shares available to lend against fewer than 5 million already borrowed. Cost to borrow has collapsed from above 1% in late September to just 0.17%, the lowest level in the 30-day window and down more than 75% on the week. The lending market is sending no distress signal whatsoever. Options positioning is similarly muted: the put/call ratio of 1.31 is almost exactly in line with its 20-day average of 1.32, a z-score of essentially zero, meaning the options market is neither unusually hedged nor unusually bullish relative to recent weeks.

What made October complicated is the gap between two pieces of information arriving in sequence. The pre-announced Q3 net profit of $21.3 billion, 18% above consensus with full-year guidance raised to $81 to $85 billion, sent the ADR up 4.2% on October 16. Since then the stock has lost 2.8% on the week and 2.1% in Thursday's session alone, suggesting the initial reaction has faded and the market is now waiting for the formal results call on October 27, which is four days away. The August print provides some context: that event produced a 4.8% single-day decline and a 4.3% loss over the five days following. The formal call may revisit questions the pre-announcement did not answer in detail.

BlackRock held 9.05% of shares as of end-September, adding roughly 14.5 million shares in the period. JP Morgan Asset Management disclosed an unusually large increase of 78 million shares in the same window, taking its stake above 1% of the company. Those are the two most active institutional moves in the most recent reporting round and both ran in the same direction. The analyst picture carries a caveat: the consensus price target of around $32 is drawn from data dated January 2021 and reflects the London-listed ordinary shares, not the NYSE ADR trading near $92. The two most recent rating actions worth noting are a KBW upgrade to Outperform in December 2025 and a BofA upgrade to Buy the same month, while Jefferies moved to Hold in October 2025. No changes have been filed in the past 14 days.

The October 27 call is where the market gets the full income statement, management commentary on net interest margin trajectory in a shifting rate environment, and any update to the capital return programme beyond the completed buyback. Those details, not the headline profit number disclosed last week, are what the formal print will be tested against.